Viewing nowTelmisartan 80 mg Tablet
Telmisartan 80mg
Tablet · Prescription medication
HK inno.N Co., Ltd.

MFDS item code 201006077 · Notified 2010.10.08 · Insurance code 640005960
Treatment of essential hypertension; prevention of cardiovascular events (e.g., myocardial infarction and stroke)
This medication is used to treat essential hypertension. Additionally, it helps reduce the risk of myocardial infarction, stroke, and death from cardiovascular disease in patients aged 55 and older who are at high risk for cardiovascular disease. It can be effectively prescribed even in cases where ACE inhibitors cannot be used. This efficacy concurrently improves hypertension management and reduces cardiovascular-related risks.
1. Essential hypertension Adults: Telmisartan 40 mg should be administered orally once daily with water, and may be taken with or without food. A dose of 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. When the dose is increased, the maximum blood pressure-lowering effect is achieved 4 ∼ 8 weeks after starting treatment. This medicine has an additional blood pressure-lowering effect when administered concomitantly with thiazide diuretics such as hydrochlorothiazide. 2. Reduction of cardiovascular risk Adults: It is recommended that this medicine be administered orally at a dose of 80 mg once daily with water, and it may be taken with or without food. The risk-reduction effect on cardiovascular morbidity and mortality at doses below 80 mg has not been established. When initiating treatment with this medicine to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive medication may be required. ○ Patients with hepatic impairment Use with caution in patients with mild to moderate hepatic impairment, and do not exceed 40 mg once daily.
This medication can cause serious harm to the fetus and newborn during pregnancy, so it should be discontinued immediately if pregnancy is confirmed. This medication should not be used by those with allergies to it or its components, by pregnant or breastfeeding women, or by individuals with severe liver disease or biliary obstruction, hereditary angioedema, or moderate to severe renal impairment among diabetics. Caution is advised for elderly patients, those with high potassium levels, mild to moderate liver impairment, patients with heart valve disease or ischemic heart disease, gastrointestinal disease patients, renal artery hypertension patients, and those with severe renal dysfunction. During the course of treatment, various side effects may present, including infections, blood abnormalities, hyperkalemia, hypoglycemia, mental and neurological disturbances, cardiac rhythm disturbances, hypotension, dyspnea, gastrointestinal disorders, liver function abnormalities, skin rash, myalgia, or renal failure; if any unusual symptoms arise, medical consultation should be sought promptly. In particular, if symptoms of angioedema or severe hyperkalemia, worsening renal function, shock, or fainting occur, medication should be stopped immediately, and appropriate treatment should be received. Patients with reduced renal function should have potassium and creatinine levels checked regularly, as hypotension may occur with reduced blood volume, necessitating caution. Furthermore, when used in conjunction with other antihypertensives, certain diuretics, lithium, non-steroidal anti-inflammatory drugs (NSAIDs), interactions may occur, so it is essential to inform healthcare providers of all current medications. Women who are pregnant or planning to become pregnant should not take this medication, and breastfeeding women should avoid using it as well. Safety and efficacy in children under the age of 18 have not been established, so it is not recommended. Elderly individuals should be observed closely for a potential risk of stroke due to excessive blood pressure lowering, and careful administration is advised. In the event of overdose, symptoms such as hypotension, cardiac rhythm disturbances, dizziness, and acute renal failure may occur, and immediate medical attention should be sought. This medication should be stored out of reach of children and care should be taken with storage and handling, such as opening the packaging just before use. Caution is also needed when driving or operating machinery, as dizziness or fainting may occur.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container that protects it from air and moisture, preferably at a temperature between 1 to 30 degrees Celsius. Proper storage can help maintain the efficacy of the medication for a longer period.
White or off-white oval-shaped tablet
30 tablets/box [(10 tablets/Alu-Alu X 3)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowTelmisartan 80mg
Tablet · Prescription medication
HK inno.N Co., Ltd.

Telmisartan 40mg
Tablet · Prescription medication
Boehringer Ingelheim Korea Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Boehringer Ingelheim Korea Co., Ltd.

Telmisartan 40mg
Tablet · Prescription medication
Kwangdong Pharmaceutical Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Kwangdong Pharmaceutical Co., Ltd.

Telmisartan 40mg
Tablet · Prescription medication
Sam-il Pharmaceutical Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Samil Pharmaceutical Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Genewon Science Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.